Department of Medicine， McMaster University， and Population Health Research Institute， Hamilton Health Sciences， Hamilton， Ontario， Canada. smehta@mcmaster.caCONTEXT: Glucose-insulin-potassium (GIK) infusion is a w.....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context： Glucose-insulin-potassium (GIK) infusion is a widely applicable， low-cost therapy that has been postulated to improve mortality in pat.....
JAMA. 2005;293:427-435. The CREATE Trial Group Investigators Context： Although reperfusion therapy， aspirin， -blockers， and angiotensin-converting enzyme inhibitors reduce mortality when used early in patien.....
关注公众号
安卓客户端
